Parker, J. L., Zhang, Z. Y. and Buckstein, R. (2011) “Clinical Trial Risk in Non-Hodgkin’s Lymphoma: Endpoint and Target Selection”, Journal of Pharmacy & Pharmaceutical Sciences, 14(2), pp. 227–235. doi: 10.18433/J39P45.